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ABSTRACT 
DNA mixtures are frequently encountered in forensic casework especially 
in cases of sexual assault.  When evidence is recovered, the sample may have 
come from multiple contributors in different proportions.  The first part of this 
study examines the fidelity of contributor proportions by using the residual to 
analyze known mixture samples. The coefficient of determination between the 
expected and observed proportions was also determined and used to assess the 
fidelity of mixture proportions.  The second part of this study involved separating 
major and minor contributors in a mixture by characterizing the observed 
proportions. Results for the 2-person mixture show that as the mass of amplified 
DNA decreases, the number of allele dropouts increases. Furthermore, as mass 
decreases, the level of variation between the expected and observed proportions 
increases, as determined by the residuals and the coefficients of determination. 
In addition, as mixture proportions become more disparate the amount of 
variations between the expected and observed proportions are not as great as 
the mass. For the 3-person mixtures, as mass decreases, the residuals increase.  
 v 
Also, when the coefficient of determination of the 3-person mixtures were 
compared to those obtained with the 2-person mixtures, it was determined that 
the R2 were larger for the former.  This was a result of higher total amplification 
masses. In mixture 1:2/2:1, major and minor proportions are not distinguishable 
In mixture 1:4/4:1, major and minor proportions can be distinguished at 1 ng. In 
mixture 1:9/9:1, proportions are distinguishable at 1, and 0.5 ng. Mixtures could 
not be distinguished at the 0.25 ng level, despite proportion and is the result of 
the increase in variation with decreasing mass.   
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INTRODUCTION 
Structure of DNA 
Deoxyribonucleic acid (DNA) is the genetic blueprint of living organisms 
(1).  The structure was first described by Watson and Crick who showed that the 
molecule takes the form of a double helix (2).  The two strands are ‘antiparallel’, 
where one strand runs in the 5’ to 3’ direction and the other strand runs in the 3’ 
to 5’ direction (1).  The two strands are held together by hydrogen bonds and 
hydrophobic interactions between adjacent base pairs (3).  DNA consists of four 
types of monomeric nucleotides and each nucleotide contains 3 components.  A 
deoxyribose sugar, a nitrogenous base, and a phosphate group.  The four bases 
are Adenine (A), Cytosine (C), Guanine (G), and Thymine (T) (3). Purines A and 
G bind with pyrimidines T and C respectively (2).  While the strands are held 
together as described above, they can also be separated into two strands; a 
process known as denaturation.  Denaturation can be accomplished either by 
increasing the temperature or by adding chemicals such as urea or formamide 
(1). Both formamide and urea are highly polar and can disrupt the hydrogen 
bonds between the strands. The reverse reaction to denaturation is annealing, 
which occurs when two single strands bind together with their complementary 
strands (1).   
DNA markers 
DNA consists of ‘coding’ and ‘noncoding’ regions.  The coding regions are 
known as genes and contain information for cells to make proteins (1).  Forensic 
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scientists use markers located in these noncoding regions for human identity 
testing.  The markers chosen are highly polymorphic and have a high degree of 
discrimination (1).  The non-coding DNA is categorized into three groups 
depending on the length of the sequence.  They are satellite DNA, minisatellite 
DNA and microsatellite DNA (4).  Satellite DNA’s are several kilobases to 
megabases in length, while mini-satellite DNA’s are within 0.1-20 kilobases in 
length and microsatellite DNA’s, also known as short tandem repeats (STR) are 
usually less than 100 bases (1, 4). STRs are DNA containing core repeat units 
between two and seven nucleotides in length that are repeated from 
approximately a half dozen to several dozen times (5). Minisatellites are highly 
polymorphic due to allelic variation in repeat copy number (6). Minisatellite DNA 
was first used for human identification by Sir Alec Jeffreys during the mid-1980s.  
He referred to the multilocus probe autoradiographs as DNA ‘fingerprints’ (7). 
STR’s are the most widely used DNA identification markers in forensic science 
today (1).  
Restriction Fragment Length Polymorphism (RFLP) 
Sir Alec Jeffreys used probes to detect and hybridize the highly variable 
number tandem repeat (VNTR) regions, using restriction fragment length 
polymorphisms (RFLP) (7).  Probes contained cloned segments of a repeated 
DNA sequence from a specific minisatellite locus. The length was detected using 
a restriction endonuclease, which does not cleave the repeat unit and therefore 
creates a fragment (6). A restriction enzyme was used to cut the long DNA into 
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shorter fragments (6). The most common restriction enzyme used was HaeIII, 
which recognized the GGCC sequence and cut between GG and CC.  The 
fragments were then separated on an agarose gel, followed by a Southern blot.  
The DNA fragments were transferred to a nylon membrane and an alkaline 
solution was added to denature the DNA into single strands (1).  A 32P or 
chemiluminescent probe was then allowed to hybridize the DNA that is 
complementary in sequence (1).  Excess probes were washed away and the 
locations of the probes were detected by placing a membrane in contact with x-
ray film weight (1).  The positions of the bands were recorded and compared to 
molecular markers (1).  Although, RFLP was a great discovery for DNA testing, it 
was eventually replaced by the polymerase chain reaction (PCR). This was due 
to the fact that RFLP required a large amount of DNA (>50 ng) compared to PCR, 
was more time consuming, had limited sensitivity, and was not suitable for 
degraded DNA samples (1).  
Short Tandem Repeats (STR) markers 
There are many STR markers that exist in the human genome, but only 
selected markers are used for human identity testing (5). STRs that are currently 
used were developed either in the laboratory of Dr. Thomas Caskey at the Baylor 
College of Medicine or at the Forensic Science Service (FSS) (1).  In the United 
States, the Federal Bureau of Investigation (FBI) established a set core of 13 
STR loci for inclusion within the DNA database known as the Combined DNA 
Index System (CODIS).  The 13 core STR loci are CSF1PO, FGA, TH01, TPOX, 
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VWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, and 
D21S11.  The STRs have repeat units that are 2-7 bp in length.  Repeat 
sequences are named by the length of the repeat unit.  Dinucleotide repeats 
have two nucleotides repeats, trinucleotides have three nucleotides in the repeat 
unit, tetranucleotides have four, pentanucleotides have five, and hexanucleotides 
have six repeat units.  STRs are divided into several categories based on the 
repeat pattern.  Simple repeats contain units of identical length and sequence, 
while compound repeats contain two or more adjacent simple repeats.  Further, 
complex repeats may contain several repeat blocks of variable unit length as well 
as variable nucleotide sequences (1).  Not all alleles for an STR locus contain 
complete repeat units.  Repeats can contain non-consensus alleles that fall in 
between alleles with full repeat units.  Microvariants are alleles that contain 
incomplete repeat units.  STRs are easily amplified by the PCR and the variation 
in the number of repeats in STR markers makes it effective for human 
identification (1). To perform STR analysis, the sequence of invariant flanking 
regions surrounding the repeats must be determined (1).  Once the flanking 
sequences are known, PCR primers can then be designed and the repeat region 
amplified for analysis.   
Polymerase Chain Reaction 
The polymerase chain reaction was first discovered by Kary Mullis in 1985. 
It is a procedure in which a sequence of DNA is amplified using oligonucleotide 
primers that flank the region to be amplified.  One primer is complementary to the 
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Watson strand (5’ to 3’) and another primer is complementary to the Crick strand 
(3’ to 5).  In the original procedure the DNA is denatured and primers are allowed 
to bind by lowering the temperature to 59°C.  This is followed by extension with 
Escherichia Coli DNA polymerase I and deoxynucleotide triphosphates (dNTPs), 
resulting in a newly synthesized strand (8).  Next, detection of gene sequence 
was accomplished by solution hybridization with an end-labeled complementary 
oligomer followed by restriction endonuclease digestion, electrophoresis, and 
autoradiography (8). PCR allows targeted regions of DNA to be copied numerous 
times to yield a certain amount of DNA (1).  It is a method that consists of 
repetitive cycles of denaturation, annealing, and polymerase extension (9).  The 
components in a PCR include primers, template DNA, deoxynucleotide 
triphosphates (dNTP), Thermus aquaticus DNA Polymerase (Taq), and a buffer, 
which contains Tris-HCl, MgCl2, KCl, BSA (5).  Primers are oligonucleotides that 
recognize the end portion of the DNA template to be replicated and will anneal 
only to those sequences to which they are perfectly matched (9).  The PCR 
technique that is typical for STR analysis consists of 28-32 cycles of denaturation 
(heating) and annealing (cooling).  At 94°C, the DNA strands denature.  At 59°C, 
primers anneal to the DNA template and target the specific region to be amplified.  
At 72°C, DNA polymerase extends the primers by copying the target region using 
the dNTPs.  The entire process takes about 3 hours and each cycle is 
approximately 3 minutes (10).   
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PCR is fast, highly sensitive, automated, highly discriminating, works fairly 
well with degraded samples, and can amplify multiple loci simultaneously using 
multiplex PCR amplification (1). The use of multiple STR loci enables a high 
power of discrimination in a single test using an optimum range of 0.5-1.25 ng (5). 
Some disadvantages to using PCR as a DNA typing method are that it is less 
discriminating per locus compared with VNTRs due to a smaller number of 
alleles and less heterozygosity per locus.  There is a higher possibility of 
contamination due to extra steps for amplification, it requires expensive 
equipment, and artifacts such as stutter and unbalanced peak heights make 
interpretation of mixtures difficult (5).   
Factors influencing DNA profiles 
There are many factors that can affect the quality of the DNA profiles 
generated from evidence samples, such as the number of cycles run in the PCR, 
injection time, condition of the DNA, and the amount of template DNA to name a 
few.  It is very important to keep the number of PCR cycles to a minimum, as 
artifacts will be more apparent with increasing cycles (11).  In addition to those 
factors, analysts must also be concerned with contamination and mixtures.  
Sometimes it is difficult to identify a true allele when an artifact is present at the 
same locus.  The amount of DNA is also very important.  With low DNA mass, 
stochastic variation can occur, resulting in allele dropouts, allele drop-in, 
increased heights of stutter peaks and heterozygote imbalance (12).  Allele 
dropout occurs when an allele of the contributor cannot be visualized in the 
 7 
electropherogram (EPG) (12).  Studies have shown that a low molecular weight 
allele will amplify more efficiently than a high molecular weight allele and are thus 
less prone to dropout (13, 14).  High molecular weight DNA may not be copied as 
efficiently because it takes Taq too long to process the entire strand, resulting in 
incomplete amplification.  Allele drop-in occurs when a peak is visualized but is 
not associated with a true contributor (12).  Heterozygote imbalance occurs when 
there is a large difference between peak heights of a heterozygote (12). When 
too much DNA is present, overload and off-scale peaks can occur as well as 
instrument related artifacts and PCR related artifacts.   
Steps to STR typing 
The complete process for STR typing includes sample collection, DNA 
extraction, DNA quantitation, PCR amplification, STR allele separation and sizing, 
STR typing, profile interpretation, and statistical assessment.   After DNA is 
amplified, formamide is added as a polar substance to keep DNA denatured. It is 
then heated and immediately snap-cooled to keep DNA single stranded.  It is 
then injected into the capillary electrophoresis instrument for separation and 
sequencing. (15).  
Capillary Electrophoresis (CE) 
Capillary electrophoresis consists of a narrow capillary, two buffer vials, 
two electrodes connected to a high-voltage power supply, laser excitation source, 
fluorescent detector, an autosampler to hold the sample tubes, and a computer 
to control sample injection and detection (1).  The instrument is automated and 
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the laser is located near the end of the capillary.  DNA is detected when the 
instrument detects the fluorescent tags, which are bound to the forward primer. 
The time required for a sample to travel from injection site to the detection 
window is recorded. Smaller molecules are detected first as they travel faster 
than larger ones.  Data from CE separations are plotted with the relative 
fluorescent intensity observed from the fluorescent emission of dyes recorded as 
the signal (1).  The fluorescent signal from dyes are used to detect and quantify 
the DNA amplicons passing the detector (1). Data collected from the CE 
instrument is represented in the form of peaks on an electropherogram (EPG) 
that correspond to STR alleles amplified from the DNA template (1).  They are 
usually converted using DNA analyzing software. Each peak is measured in 
relative fluorescent units (RFU), which represents the height (16).  The area of 
each peak and the number of base pairs can also be displayed in the EPG (16).  
STR typing is usually performed using size comparisons with standardized allelic 
ladders that contain common alleles (15). The allelic ladder contains alleles of 
known repeat content (15).  However, new alleles are constantly being 
discovered that do not exactly match the allelic ladder, which can create issues 
for interpretation (15).  These “off-ladder” alleles can be variants with more or 
less of the core repeat unit than what is present in the common alleles found in 
the commercially available allelic ladder (15).  The variant alleles may contain 
partial repeats or insertions/deletions in the flanking region close to the repeat 
(15).  Tri-allelic patterns, which are 3 alleles in a locus, have been observed and 
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it is thought to occur as an “imbalance in amounts between the three alleles (type 
1).  In other words, sum of the peak heights for 2 of the alleles is approximately 
equivalent to the third allele. A type 2 tri-allelic pattern is when all three alleles 
have approximately equal peak heights (type 2) (15). 
Thresholds 
Before analyzing, DNA thresholds to aid the analyst in determining which 
peaks are likely real and which peaks are not are established and applied.  
Therefore, an analytical threshold and stochastic threshold are required.  The 
analytical threshold is the “minimum height requirement at and above which 
detected peaks can be reliably distinguished from background noise” (17).  An 
analytical threshold should be high enough to filter out noise but not too high 
where it filters out true alleles.   A stochastic threshold is a “value above which it 
is reasonable to assume that allelic dropout has not occurred within a single-
source sample” (17).   
Mixed DNA 
Forensic DNA samples are rarely perfect; they are not pristine and not 
always from a single source. Interpretation of DNA profiles from more than one 
contributor is one of the most challenging issues that DNA analysts confront.  
Usually a sample is treated as a mixture when there are multiple loci that contain 
two alleles or more (18). A mixture is defined as additional genetic material that 
was part of the sample prior to processing and contamination is additional 
genetic material that was added during processing (11).  One of the difficulties 
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when interpreting mixtures is the large number of possible combinations of 
genotypes (19).  In addition to the large number of possible combinations of 
genotypes, mixtures are also complicated by shared alleles among contributors, 
tri-allelic patterns, stochastic variation in low or degraded DNA, artifacts from the 
activity of Taq polymerase, and microvariants in primer binding sites (13).  
Degraded DNA or low quantity DNA can result in allele and locus dropout, peak 
height imbalance, and difficulty in distinguishing true alleles from artifacts (20).  
Artifacts 
Artifacts found in an EPG originate from either PCR-related artifacts such 
as stutter and minus A or instrument-related artifacts such as bleed-through.  
Stutters are theoretically caused by strand slippage during PCR, resulting in 
either the insertion or deletion of one repeat unit on the new strand.   
This is caused by the physical displacement of one repeat unit of either the 
new/copying strand or the template/copied strand.  The result is a one repeat 
unity discrepancy between the amplicons and the parent allele (21). The 
frequency of stuttering varies not only between loci but also between the alleles 
within a locus (14).  Brookes et al. showed that repeat units that have a higher 
mass of A-T content produced greater amounts of stutter products and that 
stutter ratios increased with increasing repeat numbers (21).  Allelic peaks with 
smaller heights had larger stutters (12)(22).  In other words, stutter was more 
frequent in lower amounts of DNA.   Stutter is a problem when analyzing 
mixtures, especially when DNA is degraded, because a stutter peak can be the 
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same peak height/area as the minor contributor (18).  As a result, it becomes 
difficult to distinguish whether the peak is a stutter, or a combination of stutter 
and allele (23).  Another PCR-related artifact is minus A, which occurs when the 
Taq polymerase adds an extra nucleotide to the end of a newly synthesized DNA 
strand. Taq polymerase has the tendency to add an extra adenine to a newly 
copied strand, thus the more common amplification product is an extra base 
longer than the parent strand (N+1), where N is the number of repeats in the 
parent sequence. This results in the formation of 2 strands of DNA amplified from 
the same target but differs in size by one base pair because not all copies of 
template undergoes base addition to form ‘N+1’ fragments (14). Bleed-through, 
an instrument related artifact, is a result of the instrument failing to properly 
resolve the dye colors used to label STR amplicons.  Spectral overlap can occur, 
resulting in a peak of another color being ‘pulled up’ or ‘bled through’ to another 
color (1).  That is, it occurs when one color is oversaturated and results in a ‘pull-
up peak’ under or above the main peak (14).  One way of ameliorating the 
situation is to regularly calibrate the instrument to increase the likelihood of a 
more accurate detection with fewer bleed-through artifacts.  
Distinguishable/Indistinguishable mixtures 
Mixtures can be separated into different categories; there are 
distinguishable (resolvable) mixtures, and indistinguishable (unresolvable) 
mixtures.  Distinguishable mixtures occur when alleles and genotypes can be 
assigned to their respective sources, because the major and a minor contributor 
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peaks are well-defined (20). A major contributor is the individual who contributed 
the most DNA to the sample resulting in higher peaks.  A minor contributor is the 
individual who contributed the lower amount of DNA, resulting in smaller peaks 
(18). It has been suggested that it may be possible to separate the major and 
minor components of simple mixtures by visual examination, “particularly if the 
different contributions are in the proportions of less than 1:5” (24). However, 
when the proportions approach parity, or consist of 3 or more contributors, it 
becomes difficult to distinguish the contributors (24).  Deducing the genotypes of 
one source of a 2-person mixture can be attempted when evidence are taken 
directly from an identified anatomical location or from intimate apparel, and the 
item most likely contains DNA from the individual which the item was taken (20).  
In such cases, the genotype from that individual can be subtracted from the 
mixture at each locus.  Deducing profiles from mixtures are straightforward when 
there are 2 contributors and they are heterozygous, but when there are shared 
alleles, it becomes more difficult.  If shared alleles are suspected, designation of 
unknown contributor’s alleles at a given locus must be supported by quantitative 
differences in peak heights (20). In cases where there are no quantitative 
differences in peak heights, only obligate alleles can be definitely assigned to the 
unknown contributor (20).  Obligate alleles are the alleles that were not deduced 
from the known profile.   
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Mixture ratios 
In a distinguishable mixture, alleles of the major contributor can be paired 
to determine genotypes by the height/area of the peaks. It becomes more 
complex when the minor contributor is the suspect as it may be hard to 
determine if the peak is true allele or not (25).  Major and minor contributors are 
determined first by listing all the possible genotypes at each locus and then 
calculating the ratios of the highest peak of any possible minor component to the 
lowest peak of any assumed major component (26). Mixture ratios are usually 
equivalent across all loci; therefore the allelic ratios can be calculated for any 
mixture (25).  Once mixture ratios are estimated, the expected peak height/areas 
at all loci can be used to assess whether a peak is a stutter or an allele (25).  
When the ratio of the mixture components from two individuals is less than 1:5, it 
is often possible for the analyst to distinguish the alleles into major and minor 
contributors (24). According to Buckleton et al., when the minor contributor 
represents less than ten percent of the amplified product, it is often hard to 
separate the minor contributor’s allele from stutter effects (18).  Although mixture 
proportions are relatively consistent throughout all loci, it is not the case when the 
mass of DNA is low. Many factors such as the locus, degradation, stutter, 
stochastic variation and other artifacts can cause mixture proportions to vary (27).  
As the name suggests, indistinguishable mixtures are when alleles cannot be 
paired as genotypes and attributed to a single source(s) (13).  This often occurs 
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when multiple contributors deposited similar amounts of DNA and at least one of 
the profiles cannot be assigned to a known donor (20).  
Guidelines for interpreting mixed DNA 
One of the first steps to DNA interpretation is to identify whether the profile 
is a mixture.  Mixtures usually have more than two peaks in multiple loci. Peak 
heights can be asymmetric at heterozygous loci due to differential amplification of 
alleles (14).  Differential amplification occurs when certain alleles amplify more 
efficiently than others.  Low molecular weight alleles will amplify more efficiently 
than the higher molecular weight alleles (14).  The next step is to assign alleles 
to the peaks. The third step is to identify the number of contributors in the mixture.  
Currently, there are no methods to precisely identify the number of contributors.  
A mixture is considered simple if there is more than one locus that contains four 
alleles (25).  If there are more than 4 alleles at any locus, then the mixture is 
classified as a ‘complex mixture’ due to the large number of genotype 
combinations.  The next step is to determine the approximate ‘ratio’ of the 
components in the mixture (28).  Studies have shown that DNA mixed in a variety 
of ratios is usually preserved after co-amplification (14).  If two DNA templates 
are mixed 2:1, then this approximate ratio will be maintained when the peak 
areas of the different component alleles within a locus are compared.  This is 
only true when “comparing peaks areas within a locus (intralocus ratios) and 
does not hold when comparing peak areas between different loci (interlocus 
ratios) which can vary markedly between consecutive amplifications” (14). 
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Determining the approximate ratio in a mixture is quite straightforward when 
there are no shared alleles, but it becomes more complex when there are shared 
alleles.  This is due to the different possible combinations of genotypes (21). It is 
important to list all the possible combinations for the mixture and then compare 
the profiles of the mixture to the reference sample because this sample can help 
resolve some of the complexities in the mixture analysis (28).  Finally, another 
qualified analyst should review the results.   
Number of contributors 
The most common way to estimate the number of contributors is by 
considering the maximum number of alleles present at all loci of a profile (29).  
This is, however, not always the most accurate way due to the sharing of alleles 
between contributors, also referred to as masking (29).  These ‘masking’ effects 
are most common when contributors are related.  Using simulation, previous 
studies have shown that first-degree relatives (siblings) are more likely to have 
alleles in common than second-degree relatives (cousins) or unrelated 
individuals (29).  When there are three or four alleles in multiple loci, there is a 
high certainty that the sample came from at least 2 contributors.  When there are 
greater than 4 alleles, it is more challenging to determine the number of 
contributors.  In Buckleton’s et al. results, it was determined that the probability 
that only one or two alleles present at all ten loci for a 2-person contributor is 
estimated to be approximately 1 in 4.4x10-8 (17).  This suggests that it would be 
difficult to confuse a 2-person mixture with a single source (18).  However, 3-
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person mixtures are more complex due to masking, especially when only four or 
fewer alleles are present (18).  A simulation of 4-person mixtures suggest that 
0.014% of four person mixtures show four or fewer alleles and 66% show six or 
fewer alleles (18).  In a study performed by Paoletti et al. using only the 
maximum number of alleles observed, 3% of 3-person mixtures were mistaken 
for a 2-person mixture and more than 70% of four-person mixtures were 
mistaken for 2- or 3-person mixtures (28).  When a locus with the largest number 
of different alleles was eliminated, mischaracterization of a 3-person mixture 
increases more than five-fold (29).  Mischaracterization rates decrease as the 
number of loci considered increases, as this means there are more areas for 
comparison (29).  In summary, it is difficult to determine the number of 
contributors, due to the overlapping of alleles. 
Mixture interpretation 
There are two main steps during mixture interpretation.  First, is to 
deconvolute the mixture in the evidence and second, performing a statistical 
analysis to calculate the ‘weight of the evidence’ (30). Some methods to 
deconvolute mixtures are inferring genotypes of contributors, deduction of alleles 
present in the evidence, and by distinguishing major and minor contributor(s) (30). 
Inferring genotypes is accomplished by deducing the genotypes of the 
contributors based on relative peak height proportions followed by calculating a 
point estimate of the combined match probability for the major and minor profile.  
Ladd, et al. found that inferring genotypes were not always successful.  There 
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were 10-13% incorrect genotype assignments for the major contributor and 13-
33% of incorrectly inferring genotypes for the minor contributor (13).  Some of the 
factors that he suggested when inferring genotypes were overlapping alleles 
among close relatives and the possibility of additional contributors whose alleles 
are masked by the major contributor (13).  According to Leclair et al., the three 
major problems encountered when interpreting mixtures are stutter peaks, 
heterozygote imbalance in peak heights or peak areas, and the inability to 
determine the number of shared alleles between contributors (22). 
Software/Programs for DNA mixtures 
There have been many studies aimed at improving the interpretation of 
mixtures.  Clayton et al. prepared some general guidelines to resolve DNA 
mixtures based on quantitative peak information (14).  Software programs are 
currently under development for mixture deconvolution.  Gill et al. developed a 
computer program to estimate the proportion of the individual contributors in 2-
person mixtures and to rank the genotype combination based on the residual 
sum of squares (25).  Evett et al. use peak area information to calculate the gene 
frequencies and used a model to describe the variability in scaled peak areas 
(24).  Bill et al. developed PENDULUM, a software program that uses a least 
square method to estimate the pre-amplification proportion for 2-person 
contributors and lists all the possible genotype combinations.  For the genotypes 
that were outside the heterozygous peak balance, they were eliminated for 
further analysis.  For each combination PENDULUM finds the value of the 
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mixture ratio that minimizes the sum of the squared differences between the 
observed and expected peak areas across all loci simultaneously (31).  This is 
achieved by varying the mixture ratio until the minimum residual is found.  The 
list is then scored with respect to mixture proportion.  Allelic dropout is taken into 
account, but other artifacts such as stutter are not.  The primary purpose of 
PENDULUM is to eliminate unreasonable genotype combinations by applying the 
heterozygote balance and mixture ratio guidelines.  It also ranks the genotypes, 
but not based on a probabilistic order (31). The combination with the smallest 
residual is assumed to be the best fit (31).  This method is not widely used 
because of the complexity of the associated calculations (31).    
Perlin and Szabady used linear mixture analysis (LMA) (32) and Wang et 
al. (33) used least square deconvolution (LSD) for separating mixture profiles 
using peak area information.  Both methods are based on listing all the possible 
genotypes from the mixture profile, with an assumption that the mixture 
proportion of the contributors’ DNA in the sample is constant across markers. An 
estimate of the mixture proportion is then calculated using the least square.  The 
difference between the two methods is that Perlin and Szabady use a single 
mixture proportion that was calculated using all the markers simultaneously, 
while Wang et al. estimate a mixture proportion for each marker separately and 
then eliminate genotype combinations (16).  Wang’s method provides an 
inconsistent estimate of the proportion across markers (16).   
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Cowell et al. use the probabilistic expert system (PES), which is a 
probabilistic model for relating the pre-amplification and post-amplification 
relative amounts of DNA in a mixture (16).  The model ignores artifacts such as 
stutter, and dropout alleles and assumes that the mixture consists of DNA from 2 
people. The PES can be used for establishing whether individuals, whose 
profiles have been measured, have contributed to the mixture.  It can also be 
used to predict DNA profiles of unknown contributors by separating the mixture 
into its individual components (16).  The advantage of probabilistic model-based 
approach over LMA and LSD is that there is quantification of all uncertainties 
associated with the analysis.  In addition, the posterior distribution of the mixture 
proportion can be computed (16).   
The National Institute of Standards and Technology (NIST) also 
developed Excel-based programs to aid mixture interpretation.  They are MixSTR 
and Virtual MixtureMaker (30).  MixSTR helps identify reference alleles in sets of 
mixed- source samples (35).  Alleles are inputted by the user, including all 
relevant and control reference profiles.   MixSTR then provides a list of the match 
and mis-match alleles to all samples and profiles as well as sorted summaries of 
the percent of included alleles and loci for all comparisons (34). It only considers 
the presence/absence of alleles, but not the peak heights (30).  Virtual 
MixtureMaker creates mixture combinations through pairwise comparisons of 
input STR profiles.  It returns information on the number of loci possessing 
0,1,2,3,4,5, or 6 alleles in each 2-person mixture. It is useful for selection of 
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samples in mixture or validation studies with various degrees of overlapping 
alleles in combined STR profiles.  It is also useful in checking for potentially 
related individuals in a population database (30).   
Purpose of Study: 
Two and three person mixtures are often observed in DNA profiles from 
evidence samples but can be difficult to interpret.  This study uses mixtures of 
known mass and known ratio of components to ask whether the fidelity of 
observed mixture proportion calculated using the peak height of a profile and 
expected proportion differs when total mass amplified changes and whether 
proportion makes a difference.   The second part was to analyze expected 
proportion versus observed proportion in different mixture ratios to determine 
whether there is a ratio in these data sets where major and minor contributors 
can be distinguished.   
Materials and Methods 
DNA profiles used in this study were funded by grant number NIJ 2008-DN-BK-
K158. Refer to Rakay et al. (35) for details regarding sample preparation.  
DNA Extraction  
Phenol/chloroform extraction and alcohol precipitation were performed on 
whole blood from four individuals (A, B, C, and D) to extract the DNA (35). Visible 
spectroscopy (Genesys 10S; ThermoScientific Inc, Waltham, MA) was used to 
determine the mass of each single source sample with an assumption that one 
absorbance unit corresponds to 50 ng/μl of double stranded DNA. Absorbance at 
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260 nm and 280 nm was measured to ensure minimal protein contamination. 
Each measurement was made in triplicate and the mean mass was utilized to set 
up the samples for amplifications.  The average and two standard deviation (SD) 
values of the A260:A280 ratio over all four samples were 1.8 +/- 0.2 (36).   
Two-person mixtures A+B and C+D were written as AB and CD. Three-
person mixtures A+C+D and B+A+C were written as ACD and BAC.  Using 
various ratios, 2-person and 3-person samples were made using the above 
extracted DNA samples.  The mixture ratios for 2-person samples were 1:1, 
1:2/2:1, 1:4/4:1, 1:9/9:1, and 1:19/19:1.  The targeted mass amplification for each 
mixture is shown in Table 1 and the component of each contributor is shown in 
Appendix I.  The mixture ratios for the 3-person ACD and BAC mixtures and the 
target mass amplified are shown in Tables 2 and 3 respectively. The component 
of each contributor is shown in Appendix II and III. 
 
Table 1: Two-person mixtures (AB & CD), showing the mixture ratios and the 
target mass amplified for each ratio. 
 
2-Person Mixtures 
Contributors 
Mixture 
Ratios Target mass amplified (ng) 
AB or CD 
1:1 1, 0.5, 0.25, 0.125, 0.0625 
1:2/2:1 1, 0.5, 0.25, 0.125, 0.0625 
1:4/4:1 1, 0.5, 0.25, 0.125, 0.0625 
1:9/9:1 1, 0.5, 0.25, 0.125, 0.0625 
1:19/19:1 1, 0.5, 0.25, 0.125, 0.0625 
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Table 2: Three-person mixture ACD, showing the mixture ratios and the target 
mass amplified for each ratio. 
 
3-Person Mixture 
Contributors 
Mixture 
Ratios 
Target mass amplified 
(ng) 
ACD 
3:1:1 3, 1.7, 0.8, 0.4 0.2 
6:1:1 4, 2, 1, 0.5, 0.25 
3:2:1 3, 1.5, 0.7, 0.4, 0.2 
3:1:2 3, 1.5, 0.7, 0.4, 0.2 
12:1:1 5, 2.5, 1.2, 0.6, 0.3 
3:4:1 2.5, 1.3, 0.7, 0.3, 0.2 
3:1:4 2.5, 1.3, 0.7, 0.3, 0.2 
 
 
Table 3: Three-person mixtures BAC, showing the mixture ratios and the target 
mass amplified for each ratio. 
 
3-Person Mixture 
Contributors 
Mixture 
Ratios 
Target mass amplified 
(ng) 
BAC 
1.6:3:1 4, 2, 1, 0.5, 0.2 
3:1:1 3.5, 2, 1, 0.5, 0.2 
1.5:6:1 4, 2, 1, 0.5, 0.3 
1.5:3:2 3, 1.5, 0.8, 0.4, 0.2 
6:3:1 3.5, 1.7, 0.8, 0.4, 0.2 
1.6:12:1 5, 2.5, 1.2, 0.6, 0.3 
1.6:3:4 3, 1.5, 0.7, 0.4, 0.2 
 
 
Amplification  
The mixtures were amplified using Applied Biosystems’ AmpFlSTR® 
Identifier™ PCR Amplification Kit (Applied Biosystems, Foster City, CA). 
Amplification was carried out according to the manufacturer’s protocol, with an 
additional 60 minutes extension at the completion of 28 cycles.  Amplifications 
were performed using the Applied Biosystem’s GeneAmp® PCR System 9700 
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(Applied Biosystems Inc.) under 9600 emulation mode.  Positive and negative 
amplification controls were run and showed expected results (data not included).  
Capillary Electrophoresis  
Applied Biosystems’ 3130 Genetic Analyzer was used to separate the 
amplified STR fragments. A volume of 9 μl of highly deionized formamide and 
GeneScan™ 600 LIZ™ Size Standard (Applied Biosystems, Foster City, CA) and 1 
μl of sample or ladder were added to the appropriate wells. The samples were 
placed on a heating block at 95°C for 3 minutes, and snap-cooled at -20°C for 3 
minutes.  Injection times of 2, 5, and 10-seconds at 3 kV were used for each 
sample and the electrophoresis was run according to the manufacturers 
recommended protocol (35).   
Data Analysis 
The samples for 2- and 3- person mixtures were analyzed using 
GeneMapper® ID Version 3.2 (Applied Biosystems, Foster City, CA) (36).  
Analyzed data consisted of the sample name, allele designation, and peak size in 
base pairs and peak height in relative fluorescence units (RFU).  An analytical 
threshold of 30 RFU was used during analysis.  Although all samples were 
injected at 2, 5, and 10-seconds, only the 10-second profiles were used in this 
study. Since the genotypes of the DNA profiles were known (Appendix IV), 
alleles that were not labeled at the 30 RFU threshold could be viewed if they 
were present above baseline by enlarging the view in GeneMapper® ID and 
identifying the Y value (height in RFU) for peaks in the position of an expected 
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allele, but below threshold. If these peaks were observed and exhibited an 
appropriate shape and did not appear to be noise or artifacts from the instrument, 
the cursor of the mouse was placed at the peak to determine its Y value (height 
in RFU).  The lowest RFU that was used was 10. The number of dropouts was 
determined for allele(s) that were not recovered using the Y value. The 
proportion of allele dropouts was calculated by dividing the total number of 
dropouts by the total number of possible alleles.  Amelogenin peaks were not 
considered in this calculation. For the 1:1 mixtures, the total number of allele 
dropouts was divided by 120 [15 loci per profile X 4 alleles/locus X 2 mixtures (ie. 
AB & CD).  For other mixtures, the number of allelic dropouts was divided by 240 
[15 loci per profile X 4 alleles/locus X 2 mixtures X 2 combination (ie. 1:2 & 2:1).  
For homologous alleles, the allele was counted twice.   
All data analyzed by GeneMapper® ID was exported to Microsoft Excel 
2011 Version 14.2.3 for further analysis. The contributor proportion (PC) for each 
2-person mixture at each ratio is shown in Table 4.  Tables 5 and 6 show 
contributor proportions for the 3-person mixture ACD and BAC respectively.   
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Table 4: Known contributor proportions for 2-person mixtures AB & CD.  
 
Proportions of each contributor (Pc) 
  A (C) B (D) 
1:1 0.5 0.5 
1:2 0.33 0.67 
1:4 0.2 0.8 
1:9 0.1 0.9 
1:19 0.05 0.95 
 
 
Table 5: Known contributor proportions for 3-person mixtures ACD. 
 
Proportions of each contributor (Pc) 
 
A C D 
3:1:1 0.6 0.2 0.2 
6:1:1 0.75 0.125 0.125 
3:2:1 0.5 0.333 0.167 
3:1:2 0.5 0.167 0.333 
12:1:1 0.857 0.071 0.071 
3:4:1 0.375 0.5 0.125 
3:1:4 0.375 0.125 0.5 
 
Table 6: Known contributor proportions for 3-person mixtures BAC. 
 
Proportions of each contributor (Pc) 
 
B A C 
1.6:3:1 0.286 0.536 0.179 
3:3:1 0.429 0.429 0.143 
1.5:6:1 0.176 0.706 0.118 
1.5:3:2 0.231 0.462 0.308 
6:3:1 0.600 0.300 0.100 
1.6:12:1 0.110 0.822 0.068 
1.6:3:4 0.186 0.349 0.465 
 
 
For each combination of target DNA amplified and mixture ratio the 
expected proportion and observed proportion of RFU for each allele was 
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calculated. Calculating the expected proportion takes into account shared alleles, 
zygosity, and whether the sample is a 2 or 3-person mixture.  
When determining the expected allele proportion for unshared alleles, the 
following 2 equations were utilized,  
𝑃𝐴𝑈 = 𝑃𝐶   (ℎ𝑜𝑚𝑜𝑧𝑦𝑔𝑜𝑢𝑠 𝑝𝑎𝑖𝑟)                                                                         (1) 
𝑃𝐴𝑈 = 𝑃𝐶2   ( ℎ𝑒𝑡𝑒𝑟𝑧𝑦𝑔𝑜𝑢𝑠  𝑝𝑎𝑖𝑟)                                                                       (2) 
where PAU is the expected proportion of an unshared allele, PC is the known 
contributor proportion to the mixture (Tables 4-6).  For example, with a 1:1 ratio, 
each contributor proportion is 0.5 and the proportion for a homozygote allele from 
one contributor would be 0.5.  For the 1:1 ratio, if both contributors are 
heterozygous and no alleles are shared, each contributor has a proportion of 0.5, 
and the expected proportion for each allele would be [0.5
2
] = 0.25.   
When determining the expected proportion for shared alleles, the following 
equation was used,  
𝑃𝐴𝑆 = 𝑃𝐴𝐶1 + 𝑃𝐴𝐶2 + 𝑃𝐴𝐶3 …𝑃𝐴𝐶𝑛                                                                      (3) 
where PAS  is the total proportion of shared alleles,  PAC1 is the known proportion 
of the shared allele from contributor 1 and PAC2  is the known proportion of the 
shared allele from contributor 2 and n ranges from 1 to the number of 
contributors.  For example, with a 1:1 ratio, if the genotype for contributor 1 is 
10,11 and genotype for contributor 2 is 11,12, the expected proportion for allele 
11 is [0.5 
2
+ 0.5 
2
] = 0.5.   
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The expected proportion can then be compared to the observed 
proportion using the following equation: 
𝑃𝐴𝑂 = 𝑅𝐹𝑈𝐴 𝑅𝐹𝑈𝑇𝑜𝑡𝑎𝑙                                                                                                   (4) 
where RFUA  is the RFU for allele A and the denominator represents the sum of 
all the RFUs in a locus. 
After the expected and observed proportions for each allele were 
calculated, the data from 2-person mixtures with the same ratio (1:2 or 2:1) were 
combined followed by combining equivalent data from the AB & CD pairs having 
the same target mass amplified.  For example, data from AB 1:2 and AB 2:1 
amplified at 1 ng was joined with data from CD 1:2 and 2:1 amplified at 1 ng. The 
combined data was then sorted by the expected allele proportion.  
The difference (D) between the observed allele proportion (PO) and expected 
allele proportion (PA) was calculated as: 
𝐷 = 𝑃𝑂 − 𝑃𝐴                                                                                                          (5) 
and the residual (R) was:  
𝑅 = 𝐷2                                                                                                                   (6) 
The data was divided into sets by the amount of DNA amplified (target) and 
known ratio of contributors.  For the 2-person mixtures (AB & CD combined), 
there were 5 different targets at 5 different ratios, which made for a total of 25 
sets. For the 3-person mixtures, ACD and BAC, there were another 25 sets each.  
In total, there were 75 sets for all the mixtures.  For each data set, the residual 
was plotted for each of the expected proportions.  
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For each data set, the expected allele proportions and the observed allele 
proportions were plotted as a scatter graph.  A ordinary least squares linear 
regression was performed.  The equation of the line was determined for the 2 
and 3-person data sets. This data is used in the second part of the study to 
consider whether major and minor contributors can be distinguished in the 1:2, 
1:4, and 1:9 mixtures.  
Results 
Two-person mixtures: 
The frequency of allelic dropout for each mixture ratio at each target is 
shown in Figure 1.  In general, as mass decreases, and mixture proportions are 
more disparate, the number of allelic dropout increases. These dropouts were 
not recovered when additional observations were made by looking below the 30 
RFU threshold as described in the materials and methods section. Caragine et al. 
note a similar trend in single source samples showing that allele dropout 
increases as the target DNA mass decreases.   
For the ACD mixtures, there was a single allele dropout at 0.2 ng in 
mixture 3:1:4, and one allele dropout at 0.2 ng in mixture 3:2:1.  For the BAC 
mixturess dropouts were observed in the following samples: 
a) One dropout in 1.6:3:1 at 0.5 ng 
b) Five dropouts in 1.6:3:4 at 0.2 ng 
c) One dropout in 1.5:6:1 at 0.2 ng 
d) One dropout in 1.5:6:1 at 0.3 ng 
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e) One dropout in 6:3:1 at 0.2 ng.    
There were no dropouts in the remaining mixtures.  There are a total of 9 
allele dropouts for the BAC mixtures.  In general, there are fewer dropouts in 
the 3-person mixtures than the 2-person mixtures.  The lowest mass amplified 
for the 2 and 3-person mixtures was 0.0625 and 0.2 ng respectively. 
 
 
Figure 1: Frequency of allelic dropouts in 2-person mixtures AB & CD for each 
target mass amplified at each mixture ratio. These are dropouts that were not 
recovered using the Y-axis in GeneMapper® ID v. 3.2.  
 
Figures 2-6 plot the residual (Equations 5 & 6) for the 2-person mixtures.  
Each figure contains 5 graphs, one for each target. The closer the data points are 
to 0, the closer the observed proportions are to the expected proportions. The 
mean residual is also presented in Figure 7.  For each mixture ratio, results show 
that as the mass amplified decreases, the residuals increases.  This shows that 
at low amplification masses the observed proportions do not reflect the observed 
proportions as reliably as when larger amounts of DNA were amplified.  
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Figure 2: Expected allele proportions versus the residuals for 2-person mixtures 
AB & CD for the 1:1 ratio, amplified using 1, 0.5, 0.25, 0.125, and 0.0625 ng.  
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Figure 3: Expected allele proportions versus the residuals for 2-person mixtures 
AB & CD for the 1:2/2:1 mixture, amplified using 1, 0.5, 0.25, 0.125, and 0.0625 
ng.  
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Figure 4: Expected allele proportions versus the residuals for 2-person mixtures 
AB & CD for the 1:4/4:1 mixtures, amplified using 1, 0.5, 0.25, 0.125, and 0.0625 
ng.  
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Figure 5: Expected allele proportions versus the residuals for 2-person mixtures 
AB & CD for the 1:9/9:1 mixture, amplified using 1, 0.5, 0.25, 0.125, and 0.0625 
ng.  
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Figure 6: Expected allele proportions versus the residuals for 2-person mixtures 
AB & CD for the 1:19/19:1 mixture, amplified using 1, 0.5, 0.25, 0.125, and 
0.0625 ng.  
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Figure 7, shows the average residual for each amplified mass (ng) and 
mixture ratio combination. As expected, when target mass decreases, the 
average residual and variance of the residual increases. Thus, the observed 
proportions are further away from predicted.  However, when mass is constant, 
there is variation in the average residual and the variance, but the residual did 
not increase as the mixture proportions became more disparate.  
 
Figure 7: Graph of the average residual for 2-person mixtures AB & CD for each 
ratio at each target DNA amount.  Each color represents a different ratio.  Error 
bars represent variance.   
 
Figure 8 shows the difference between observed and expected 
proportions at 1:2/2:1 and 1:19/19:1 at 1 and 0.0625 ng, which contain 4 of the 2-
person mixtures. The figures illustrate that when mass decreases and the 
mixture ratio remains constant, the difference between observed and expected 
proportion increases.  However, as the mixture ratio becomes more disparate 
0
0.005
0.01
0.015
0.02
0.025
1 ng 0.5 ng 0.25 ng 0.125 ng 0.0625 ng
Av
er
ag
e 
Re
si
du
al
 
Nanograms Amplified 
1:11:2/2:11:4/4:11:9/9:11:19/19:1
 36 
and the mass amplified remains the same, the spread of the difference between 
observed and expected proportion does not increase. This suggests that the total 
mass amplified was more important in determining the accuracy of the 
proportions than the difference in mixture ratio.   
        
 
       
 
Figure 8: 1 ng at 1:2/2:1 and 1:19 &19:1 and 0.0625 ng at 1:2/2:1 ng and 1:19 & 
19:1 showing the difference between the observed and expected allele 
proportions for the 2-person mixtures AB & CD. 
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Figures 9-13 plot the expected allele proportions versus the observed 
proportions for the 2-person mixture data sets.  A coefficient of determination (R2) 
and regression equation was determined for each DNA target and is shown in 
each plot. Refer to Appendix V for the values of expected proportions for each 
ratio of contributors. 
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Figure 9: Expected allele proportions versus the observed allele proportions for 
2-person mixtures AB & CD for the 1:1 ratio, amplified using 1, 0.5, 0.25, 0.125 
and 0.0625 ng. The R2 and regression equation are included in each graph.   
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Figure 10: Expected allele proportions versus the observed allele proportions for 
2-person mixtures AB & CD for the 1:2/2:1 ratio, amplified using 1, 0.5, 0.25, 
0.125 and 0.0625 ng. The R2 and regression equation are included in each graph. 
The unshared minor, unshared major and shared allele proportions are indicated 
in the first graph and the same applies for all the graphs.   
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Figure 11: Expected allele proportions versus the observed allele proportions for 
the 2-person mixtures AB & CD for the 1:4/4:1 ratio, amplified using 1, 0.5, 0.25, 
0.125 and 0.0625 ng. The R2 and regression equation are included in each graph. 
The unshared minor, unshared major and shared alleles are indicated in the first 
graph and the same applies for all the graphs.   
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Figure 12: Expected allele proportions versus the observed allele proportions for 
2-person mixtures AB & CD for the 1:9/9:1 ratio, amplified using 1, 0.5, 0.25, 
0.125 and 0.0625 ng. The R2 and regression equation are included in each graph.  
The unshared minor, unshared major and shared alleles are indicated in the first 
graph and the same applies for all the graphs.   
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Figure 13: Expected allele proportions versus the observed allele proportions for 
the 2-person mixtures AB & CD for the 1:19/19:1 ratio, amplified using 1, 0.5, 
0.25, 0.125 and 0.0625 ng. The R2 and regression equation are included in each 
graph.  The unshared minor, unshared major and shared alleles are indicated in 
the first graph and the same applies for all the graphs.   
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 Table 7 shows the summary of the R2, the y-intercepts and slopes for 
each mass amplified in each mixture ratio.  As the mass amplified decreases, the 
R2 decreases.  As with the examination of the residual values, this implies that 
when the amount of DNA amplified decreases, the observed proportions show 
greater variation from the expected proportions.   
 
Table 7: Shows the R2, the y-intercepts, and slopes for the 2-person mixtures AB 
& CD for each mixture ratio at each mass amplified.   
 
Mixture 
Ratio 
 
Mass Amplified 
1 ng 0.5 ng 0.25 ng 0.125 ng 0.0625 ng 
1:1 
R2 0.924 0.897 0.851 0.584 0.581 
y-intercept 0.016 0.006 0.026 0.059 0.038 
slope 0.953 0.984 0.925 0.848 0.909 
1:2/2:1 
R2 0.961 0.916 0.83 0.712 0.503 
y-intercept 0.013 0.026 0.002 0.016 0.081 
slope 0.964 0.927 0.999 0.965 0.814 
1:4/4:1 
R2 0.973 0.964 0.916 0.845 0.786 
y-intercept 0.013 0.014 0.015 0.032 0.032 
slope 0.963 0.961 0.961 0.916 0.956 
1:9/9:1 
R2 0.96 0.953 0.923 0.89 0.723 
y-intercept 0.028 0.03 0.026 0.031 0.074 
slope 0.923 0.919 0.932 0.93 0.856 
1:19/19:1 
R2 0.991 0.983 0.973 0.923 0.809 
y-intercept 0.006 0.004 0.006 0.0318 0.058 
slope 0.984 0.99 0.986 0.932 0.886 
 
Distinguishing major and minor proportions: 2-person mixtures 
Data from this research may also be useful in determining whether there is 
a ratio in each data set where major and minor contributors can be distinguished. 
For the 1:2/2:1, 1:4/4:1 and 1:9/9:1, the highest observed minor homozygote 
allele is compared to the lowest observed major heterozygote allele to determine 
 44 
if there are any overlapping proportions.  At the 1:2/2:1 ratio (Figure 10), major 
and minor proportions cannot be distinguished because the major heterozygote 
allele proportions and the minor homozygote allele proportions are close to each 
other with a PA= 0.335 and PA=0.333 respectively.  The expected allele 
proportions for each 2-person mixture ratio are listed in Appendix V.  For the 
1:4/4:1 ratio (Figure 11), there are no overlapping observed proportions at 1 ng 
between major expected PA of 0.4 and minor PA of 0.2 at homozygote alleles. For 
the 1:9/9:1 ratio, there are no overlapping observed proportions at 1 and 0.5 ng 
between major (PA= 0.45) and minor heterozygote (PA= 0.1) alleles. In all data 
sets when contributor proportions are close in value, assigning alleles to 
contributors becomes more difficult.  In general decreasing the mass amplified 
results in greater variation in allele proportions and distinguishing proportions 
originating from different contributors becomes difficult. 
Three-person mixtures: 
Figures 14-20 show expected proportions versus residuals for the ACD 
mixture set.  At all ratios the residuals increase as the mass amplified decreases.  
Although this occurs to a lesser extent in the 6:1:1 and 12:1:1 mixture sets.  This 
general trend is similar to that observed in the 2-person mixtures.   
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Figures 14: Shows the expected allele proportions versus the residuals for the 3-
person mixtures ACD for the 3:1:1 ratio, amplified using 3, 1.7, 0.8, 0.4, and 0.2 
ng. 
 
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0 0.5 1
R
es
id
ua
ls
 
Expected Proportions  
3 ng at 3:1:1 
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0 0.5 1
R
es
id
ua
ls
 
Expected Proportions  
1.7 ng at 3:1:1 
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0 0.5 1
R
es
id
ua
ls
 
Expected Proportions 
0.8 ng at 3:1:1 
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0 0.5 1
R
es
id
ua
ls
 
Expected Proportions  
0.4 ng at 3:1:1 
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0 0.5 1
R
es
id
ua
ls
 
Expected Proportions  
0.2 ng at 3:1:1 
 46 
      
 
      
 
 
 
Figures 15: Shows the expected allele proportions versus the residuals for the 3-
person mixtures ACD for the 3:2:1 ratio, amplified using 3, 1.5, 0.7, 0.4 and 0.2 
ng.  
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Figures 16: Shows the expected allele proportions versus the residuals for the 3-
person mixtures ACD for the 3:1:2 ratio, amplified using 3, 1.5, 0.7, 0.4, and 0.2 
ng. 
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Figure 17: Shows the expected allele proportions versus the residuals for the 3-
person mixtures ACD for the 3:4:1 ratio, amplified using 2.5, 1.3, 0.7, 0.3, and 0.2 
ng. 
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Figure 18: Shows the expected allele proportions versus the residuals for the 3-
person mixtures ACD for the 3:1:4 ratio, amplified using 2.5, 1.3, 0.7, 0.3 and 0.2 
ng. 
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Figure 19: Shows the expected allele proportions versus the residuals for the 3-
person mixtures ACD for the 6:1:1 ratio, amplified using 4, 2, 1, 0.5, and 0.25 ng. 
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Figure 20: Shows the expected allele proportions versus the residuals for the 3-
person mixtures ACD for the 12:1:1 ratio, amplified using 5, 2.5, 1.2, 0.6 and 0.3 
ng. 
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 Figure 21 shows the average residual for the 3-person ACD mixtures for 
each ratio at each target DNA amount. The figure shows, that in general as mass 
decreases the average residual increases.  In some cases outliers seen in the 
data result in a break in this trend, such as 0.8 ng for the 3:1:1 ratio. For mixture 
ratio 6:1:1 and 12:1:1, the average residual was approximately the same for all 
masses.  The variance is represented by the error bars and is very small for all 
the mixtures. 
   
 
      
 
Figure 21: Shows summary data for the average residuals for each 3-person 
ACD mixtures at each ratio of target DNA amplified.  The mixture ratio is shown 
as the title of each graph.  Error bars represent the variance.   
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Figure 21 continued: Shows summary data for the average residuals for each 3-
person ACD mixtures at each ratio of target DNA amplified.  The mixture ratio is 
shown as the title of each graph.  Error bars represent the variance.   
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Figure 22: Expected allele proportions versus the residuals for the 3-person 
mixture BAC for the 1.6:3:1 ratio, amplified using 4, 2, 1, 0.5 and 0.2 ng.  
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Figure 23: Expected allele proportions versus the residuals for the 3-person 
mixtures BAC for the 1.5:3:2 ratio, amplified using 3, 1.5, 0.8, 0.4, and 0.2 ng.  
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Figure 24: Expected allele proportions versus the residuals for the 3-person 
mixtures BAC for the 1.6:3:4 ratio, amplified using 3, 1.5, 0.7, 0.4, and 0.2 ng.   
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Figure 25: Expected allele proportions versus the residual for the 3-person 
mixtures BAC for the 1.5:6:1 ratio, amplified using 4, 2, 1, 0.5, and 0.3 ng.  
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Figure 26: Expected allele proportions versus the residuals for the 3-person 
mixtures BAC, amplified using 1.6:12:1 at 5, 2.5, 1.2, 0.6, and 0.3 ng.  
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Figure 27: Expected allele proportions versus the residuals for the 3-person 
mixtures BAC for the 3:3:1 ratio, amplified using 3.5, 2, 1, 0.5, and 0.2 ng. Note 
that y-axis at 0.2 ng is different. 
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Figure 28: Expected allele proportions versus residuals for the 3-person mixtures 
BAC for the 6:3:1 ratio, amplified using 3.5, 1.7, 0.8, 0.4 and 0.2 ng.  
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Figure 29 shows the average residual for the 3-person BAC mixtures for 
each ratio and each target DNA amount. The error bars represent the variance.  
Similar to the other 3-person ACD mixture, as nanograms amplified decreases, 
the average residual increases.  The variance was low for all the mixtures. For 
the 1.6:12:1 ratio, the average residuals were approximately the same for all 
masses.  
        
 
        
Figure 29: Shows the average residual for the 3-person mixtures BAC for each 
ratio at each target DNA amplified.  Each plot represents ratios 1.6:3:1, 1.5:3:2, 
1.6:3:4, 1.5:6:1, 1.6:12:1, 3:3:1, and 6:3:1. Error bars represent the variance.    
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
4 2 1 0.5 0.2
A
ve
ra
ge
 R
es
id
ua
ls
 
Nanograms Amplified 
1.6:3:1 
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
3 1.5 0.8 0.4 0.2
A
ve
ra
ge
 R
es
id
ua
ls
 
 
Nanograms Amplified 
1.5:3:2 
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
3 1.5 0.7 0.4 0.2
A
ve
ra
ge
 R
es
id
ua
ls
 
Nanograms Amplified 
1.6:3:4 
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
4 2 1 0.5 0.3
A
ve
ra
ge
 R
es
id
ua
ls
 
Nanograms Amplified 
1.5:6:1 
 62 
        
 
 
Figure 29 continued: Shows the average residual for the 3-person mixtures BAC 
for each ratio at each target DNA amplified.  Each plot represents ratios 1.6:3:1, 
1.5:3:2, 1.6:3:4, 1.5:6:1, 1.6:12:1, 3:3:1, and 6:3:1. Error bars represent the 
variance.   
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relationship between the expected proportions and the observed proportions.  In 
general, there was a slight decrease in R2 as mass amplified decreases.  
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BAC mixtures where no decrease was observed and instead a slight increase 
occurred. These observations are highlighted in Table 8 and 9 respectively. 
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Figure 30: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures ACD for the 3:1:2 ratio, amplified using 3, 1.5, 0.7, 0.4, 
and 0.2 ng.  The R2 and regression equation are included in each graph.  
 
y = 0.9592x + 0.0107 
R² = 0.9688 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
3 ng at 3:1:2 
y = 0.9513x + 0.0128 
R² = 0.958 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
1.5 ng at 3:1:2 
y = 0.9449x + 0.0145 
R² = 0.964 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
0.7 ng at 3:1:2 
y = 0.9259x + 0.0195 
R² = 0.915 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
0.4 ng at 3:1:2 
y = 0.9674x + 0.0086 
R² = 0.8577 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
0.2 ng at 3:1:2 
 65 
      
 
      
 
 
 
Figure 31: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures ACD for the 3:2:1 ratio, amplified using 3, 1.5, 0.7, 0.4, 
and 0.2 ng.  The R2 and regression equation are included in each graph.  
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Figure 32: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures ACD for the 3:1:4 ratio, amplified using 2.5, 1.3, 0.7, 0.3, 
and 0.2 ng.  The R2 and regression equation are included in each graph.  
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Figure 33: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures ACD for the 3:4:1 ration, amplified using 2.5, 1.3, 0.7, 0.3, 
and 0.2 ng.  The R2 and regression equation are included in each graph.  
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Figure 34: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures ACD for the 3:1:1 ratio, amplified using 3, 1.7, 0.8, 0.4, 
and 0.2 ng.  The R2 and regression equation are included in each graph.  
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Figure 35: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures ACD for the 6:1:1 ratio, amplified using 4, 2, 1, 0.5, and 
0.25 ng. The R2 and regression equation are included in each graph.  
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Figure 36: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures ACD for the 12:1:1 ratio, amplified using 5, 2.5, 1.2, 0.6, 
and 0.3 ng. The R2 and regression equation are included in each graph.  
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Figure 37: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures BAC for the 1.6:3:1 ratio, amplified using 4, 2, 1, 0.5, and 
0.2 ng. The R2 and regression equation are included in each graph.  
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Figure 38: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures BAC for the 1.5:3:2 ratio, amplified using 3, 1.5, 0.8, 0.4, 
and 0.2 ng. The R2 and regression equation are included in each graph.  
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Figure 39: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures BAC for the 1.6:3:4 ratio, amplified using 3, 1.5, 0.7, 0.4, 
and 0.2 ng. The R2 and regression equation are included in each graph.  
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Figure 40: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures BAC for the 1.5:6:1 ratio, amplified using 4, 2, 1, 0.5, and 
0.3 ng. The R2 and regression equation are included in each graph.  
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Figure 41: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures BAC for the 1.6:12:1 ratio, amplified using 5, 2.5, 1.2, 0.6, 
0.3 ng. The R2 and regression equation are included in each graph. 
 
y = 0.9329x + 0.018 
R² = 0.9867 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
5 ng at 1.6:12:1 
y = 0.9417x + 0.0156 
R² = 0.9879 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
 
Expected Proportions  
2.5 ng at 1.6:12:1 
y = 0.9314x + 0.0184 
R² = 0.981 
0
0.2
0.4
0.6
0.8
1
0 0.5 1
O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
1.2 ng at 1.6:12:1 
y = 0.9269x + 0.0196 
R² = 0.9705 
0
0.2
0.4
0.6
0.8
1
0 0.5 1O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
0.6 ng at 1.6:12:1 
y = 0.9313x + 0.0184 
R² = 0.9674 
0
0.2
0.4
0.6
0.8
1
0 0.5 1O
bs
er
ve
d 
Pr
op
or
tio
ns
  
Expected Proportions  
0.3 ng at 1.6:12:1 
 76 
      
 
      
 
 
 
Figure 42: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures BAC for the 3:3:1 ratio, amplified using 3.5, 2, 1, 0.5 and 
0.2 ng. The R2 and regression equation are included in each graph. 
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Figure 43: Expected allele proportions versus the observed allele proportions for 
the 3-person mixtures BAC for the 6:3:1 ratio, amplified using 3.5, 1.7, 0.8, 0.4, 
and 0.2 ng. The R2 and regression equation are included in each graph. 
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Tables 8 and 9 show the coefficient of determination (R2), the y-intercepts 
and slopes for each mass amplified at each mixture ratio for the 3-person 
mixtures ACD.    The R2 values can fall between 0 and 1, to indicate how well a 
regression line fits a data set.  A R2 value close to 1 indicates that a regression 
line fits the data well, while R2 close to 0 means data did not fit the regression line 
well.  The R2 in this data ranged from 0.989 to 0.761.  The highest R2 of 0.989 
means that 99% of the total variation in y can be explained by the linear 
relationship between x and y as for our low range, 76% of y can be explained.   
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Table 8: Shows the R2, the y-intercepts and slopes for all the ACD mixtures. 
Highlighted areas indicate the lower mass has a higher R2 than the higher mass. 
 
 
 
 
 
Mixture 
Ratio   Mass Amplified 
3:1:2 
  3 ng 1.5 ng  0.7 ng 0.4 ng 0.2 ng 
R2 0.969 0.958 0.964 0.915 0.858 
y-intercept 0.011 0.013 0.015 0.02 0.009 
slope 0.959 0.951 0.945 0.926 0.967 
3:2:1 
  3 ng 1.5 ng 0.7 ng 0.4 ng 0.2 ng 
R2 0.938 0.921 0.953 0.823 0.761 
y-intercept 0.028 0.023 0.021 0.031 0.045 
slope 0.894 0.911 0.921 0.884 0.837 
3:1:4 
  2.5 ng 1.3 ng 0.7 ng 0.3 ng 0.2 ng 
R2 0.965 0.97 0.959 0.927 0.904 
y-intercept 0.017 0.018 0.021 0.004 0.03 
slope 0.936 0.931 0.919 0.984 0.894 
3:4:1 
  2.5 ng 1.3 ng 0.7 ng 0.3 ng 0.2 ng 
R2 0.956 0.97 0.95 0.945 0.879 
y-intercept 0.001 0.006 0.005 0.011 0.002 
slope 1.004 1.024 0.982 1.043 0.993 
3:1:1 
  3 ng 1.7 ng 0.8 ng 0.4 ng 0.2 ng 
R2 0.981 0.967 0.877 0.937 0.906 
y-intercept 0.013 0.016 0.03 0.014 0.006 
slope 0.952 0.94 0.887 0.946 0.978 
6:1:1 
  4 ng 2 ng 1 ng 0.5 ng 0.25 ng 
R2 0.981 0.979 0.956 0.951 0.946 
y-intercept 0.024 0.035 0.043 0.025 0.027 
slope 0.91 0.866 0.834 0.904 0.896 
12:1:1 
  5 ng 2.5 ng 1.2 ng 0.6 ng 0.3 ng 
R2 0.986 0.987 0.989 0.977 0.968 
y-intercept 0.027 0.027 0.026 0.03 0.02 
slope 0.892 0.898 0.9 0.883 0.925 
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Table 9: Shows the R2, the y-intercepts, and slopes for all the BAC mixtures.  
Highlighted areas indicate the lower mass has a higher R2 than the higher mass. 
 
Mixture 
Ratio   Mass Amplified 
1.6:3:1 
  4 ng 2 ng 1 ng 0.5 ng 0.2 ng 
R2 0.972 0.977 0.963 0.893 0.862 
y-intercept 0.015 0.008 0.001 0.014 0.018 
slope 0.946 0.972 1.002 0.955 0.974 
1.5:3:2 
  3 ng 1.5 ng 0.8 ng 0.4 ng 0.2 ng 
R2 0.964 0.963 0.951 0.9 0.838 
y-intercept 0.008 0.006 0.015 0.022 0.02 
slope 0.97 0.98 0.943 0.92 0.924 
1.6:3:4 
  3 ng 1.5 ng 0.7 ng 0.4 ng 0.2 ng 
R2 0.963 0.968 0.949 0.887 0.895 
y-intercept 0 -0.013 -0.012 0.003 -0.025 
slope 0.999 1.047 1.045 0.991 1.099 
1.5:6:1 
  4 ng 2 ng 1 ng 0.5 ng 0.3 ng 
R2 0.983 0.985 0.967 0.945 0.914 
y-intercept 0.02 0.02 0.024 0.02 0.029 
slope 0.925 0.927 0.012 0.925 0.898 
1.6:12:1 
  5 ng 2.5 ng 1.2 ng 0.6 ng 0.3 ng 
R2 0.987 0.989 0.981 0.971 0.967 
y-intercept 0.018 0.016 0.018 0.02 0.018 
slope 0.933 0.942 0.931 0.927 0.931 
3:3:1 
  3.5 ng 2 ng 1 ng 0.5 ng 0.2 ng 
R2 0.975 0.963 0.942 0.909 0.834 
y-intercept 0.02 0.017 0.022 0.018 0.03 
slope 0.925 0.938 0.917 0.934 0.87 
6:3:1 
  3.5 ng 1.7 ng 0.8 ng 0.4 ng 0.2 ng 
R2 0.943 0.936 0.933 0.919 0.832 
y-intercept 0.034 0.037 0.027 0.035 0.056 
slope 0.873 0.861 0.899 0.869 0.798 
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Discussion: 
According to Collins et al., the recommended input DNA range for forensic 
amplification is 0.5-1.25 ng for the AmpFlSTR® Identifier™ kit (38).  These 
authors state that mixtures that are within this range should be amplified 
efficiently. Clayton et al. have shown that mixture estimates are consistent across 
all loci in a multiplex amplification kit, and that DNA mixed in various ratios are 
usually preserved after co-amplification (14).  Freageau et al. found that full 
profiles were generally obtained for minor contributors using 2 ng of DNA with a 
ratio of 10:1 and using 1 ng of DNA, full profiles were observed at ratios 10:1 and 
1:8 (26).   
In this study, full profiles were observed using 1 ng for all mixture ratios.  
Allelic dropouts were observed at the target mass of 0.5 ng in the 9:1 ratio, and 
1:19/19:1 ratio for the 2-person mixtures.  Although the 0.5 ng target mass is 
typically sufficient for complete observation of the profiles, the minor component 
of the 1:9 was 0.05 ng, which explains the presence of dropouts.  This is also 
true for the 1:19 mixture.  As target mass of individual contributors decreases, 
the number of allele dropouts increases.  Allele dropout is a problem in DNA 
interpretation as observation of one allele of a heterozygous pair can be 
incorrectly interpreted as a homozygous allele, potentially incorrectly excluding a 
true contributor.   
For the 2-person mixtures, as the mass amplified decreases, the residual 
values of the component proportions and the variance increase when observed 
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proportions are compared to actual proportions.  Therefore at low mass, the 
observed proportions do not reflect the actual proportions as reliably as when 
larger target amounts of DNA are amplified. These observations were further 
supported by the coefficient of determination (R2) values calculated from the 
linear regression of observed proportions and the expected proportions.  For the 
2-person mixtures, as the mass decreases, the R2 decreases. The R2 ranged 
from 0.991 to 0.581. It should be noted that at 0.0625 ng, the R2 for the 1:1 ratio 
(0.581) was lower than the 1:19/19:1 ratio (0.809).  For the 0.0625 ng samples, 
the mass for each contributor for the 1:1 ratio is 0.0312 ng, and the mass for the 
1:19/19:1 is 0.059 and 0.003 ng.  This suggests that since the major contributor 
in 1:19/19:1 has a greater mass than each contributor in 1:1; the DNA might have 
amplified more efficiently. 
Considering mixtures amplified at constant mass and looking at samples 
with different mixture ratios, there is variation in the residual values but the 
residuals do not increase as the mixture proportions became more disparate. 
This is again supported by the R2 values, which show that as mixture ratios are 
more disparate, the observed proportions show minimal variation from the 
expected proportions unless the total mass amplified is low.  
This information is significant for method and interpretation protocol 
development, since the data suggest a mixture ratio threshold where contributors 
can be confidently deciphered can be applied. When a mixture has a mass of 
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0.125 ng and below, the suspected proportions would be less reliable due to the 
greater variation of the observed proportions and low-template samples should 
be considered indistinguishable, regardless of the mixture proportion.   
For all 3-person mixtures, the residual values and variance show little 
variation. This could be a result of the target DNA mass analyzed.  The lowest 
mass analyzed for the 3-person mixtures was 0.2 ng, while the lowest mass for 
the 2-person mixtures was 0.0625 ng. For most of the 3-person mixtures, there 
are high R2 values for the expected and observed proportions. The R2 for the two 
3 person mixture sets ranged from 0.989 to 0.761.  In general, there was a 
decrease in R2 as the mass amplified decreases. However, there were ten 
instances where no decrease was observed, but instead a slight increase 
occurred. In 6 of the 10 instances, the greater target mass was 2.5 ng and above.  
In mixture samples, if major and minor contributors were distinguishable, 
assigning genotypes to a contributor would be straightforward. According to Evett 
et al., it is visually possible to separate major and minor contributors if 
proportions are less than 1:5 ng (24).  In this study, the range of the major and 
minor heterozygote allele proportions are just barely distinguishable at 1 ng for 
the 1:2/2:1 ratio. However, when DNA mass decreases, the proportions began to 
overlap.  In the 1:4/4:1 mixture, major and minor heterozygote allele proportions 
were distinguishable at 1 and 0.5 ng, but at 0.25 ng and below, the distinction 
becomes unclear due to overlapping values of the observed proportions.  
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Although the heterozygote allele proportions for the major and minor contributor 
are distinguishable, the allele proportions observed when the minor allele is 
homozygous compared to when the minor allele is heterozygous are not 
distinguishable. The same situation occurs between the proportions for a major 
homozygous allele and a major heterozygous allele.  For the 1:9/9:1 mixture, the 
major and minor heterozygous allele proportions are distinguishable as low as 
0.125 ng. However, proportions for a minor homozygous allele and a minor 
heterozygous allele are not distinguishable. This also applies to proportions for 
the major homozygous allele and major heterozygote allele.  
Using data shown in Figures 30-43, it is not possible to distinguish the 
allele proportions between major and minor contributors for the 3-person 
mixtures.  There are a larger number of allele proportions possible due to 
increased number of alleles in the 3-person mixtures and the sharing of alleles. 
For mixtures with three contributors there are 150 possible combinations of 
alleles, which could be observed (39).  
The data also allowed comparison of the proportion variation between 
shared and non-shared allele proportions. Figures 10-12 and 30-43 show data 
for all observed proportions.  These proportions arise from alleles that are both 
shared and not shared (Appendix V). The range of observed proportion values 
was similar for shared and non-shared alleles.  While there is greater deviation 
as mass amplified decreases, there is little difference noted in the extent 
variation for shared and non-shared alleles for all mixture sets.  
Appendix I- Total mass in ng of DNA amplified and mass of each contributor for the 2-person  
mixtures (AB & CD).  
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     Appendix  II- Total mass in ng of DNA amplified and mass of each contributor for the ACD mixtures.  
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                 Appendix III: Total mass in ng of DNA amplified and mass of each contributor for the BAC mixtures. 
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    Appendix IV: Table of alleles for contributors A, B, C and D.  
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Appendix V: Allele proportions for the 2-person mixtures  (AB & CD) at each ratio. Asterisk indicates  
shared alleles.   
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